Oxazepam Antikörper
Kurzübersicht für Oxazepam Antikörper (ABIN1001448)
Target
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- Oxazepam
-
Spezifität
- ELISA microtitre plate based and expressed as % crossreactivity*. The antibody exhibited crossreactivity for the following compounds: Lorazepam < 5.1 % ,Nitrazepam 187.9 %,Flunitrazepam < 5.1 %,7-Aminoflunitrazepam < 5.1 %,Clobazam < 5.1 %,Clonazepam 8.9 %,7-Aminoclonazepam < 5.1 %,Diazepam < 5.1 %,Nordiazepam 229.0 %, Temazepam < 5.1 %,Alprazolam < 5.1 %,Triazolam< 5.1 %,Bromazepam 29.0 %,Prazepam < 5.1 %, * crossreactivity profile may vary with tracer used.
-
Aufreinigung
- Salt fractionation.
-
Immunogen
- Oxazepam-BSA/KLH
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Application_Dilutions: 2.5 μg/mL
Tested_Applications: The antibody is suitable for the development of immunoassays or immunoaffinity purification columns.
-
Kommentare
-
10 ng/mL Oxazepam produces 93 % inhibition in a competitive ELISA employing Oxazepam polyclonal antibody.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- 20 mM Phosphate, 150 mM Sodium Chloride. pH 7.4, 0.09 % Sodium Azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Can be stored for up to 3 months at +2°C - +8°C. For long term storage, aliquot and store at ≤-20 °C. Avoid repeated freeze/thaw cycles. Product should be protected from light exposure.
-
-
- Oxazepam
-
Substanzklasse
- Chemical
-
Hintergrund
- The benzodiazepines are a group of over 20 structurally related central nervous system depressant drugs, each group varying considerably in their potency and clinical effects.
Target
-